Search

everythinglearnresearchcommunity

for

Search:↓

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The right balance of Myo-Inositol to D-Chiro-Inositol in follicular fluid is crucial for good egg and embryo quality.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

New cytokine-targeted therapies show promise for treating alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Intermediate filaments are crucial for cell structure and function, regulated by specific genes and proteins.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.